Babylon to be taken private by creditors

Shareholders in Babylon, which was worth $4.2bn at listing in October 2021, face being wiped out as it reverts to private ownership as creditor Albacore takes over. CEO and founder Ali Parsa, whose remuneration totalled $7.1m in 2022, is likely to stay on, says a legal expert who says the group could face legal action.

Finnish outsourcing opportunities slow to materialise

The SOTE reform to the Finnish health care system has been in place since January 1, 2023, but additional outsourcing opportunities have been slow to materialise. Operators are nonetheless convinced they are on the way.

FREE BLOG Why there is no quick fix for German healthcare

At times, it can feel like healthcare reform moves at the pace of an oil tanker, and currently, nowhere is this more true than in Germany. Among the issues holding the EU5 market back are an allergy to digitalisation, an inability to make unpopular decisions, and the rigidity of roles in the medical profession.

HBI Deals+Insights briefing June 2023: Deals+Insights members

Click here to see your Deals+Insights June 2023 In June’s edition we take a first look at Orpea’s restructuring plans, consider what legal challenges could mean for Germany’s hospital reforms and the Dutch competition authority, and hear digital health firm Babylon will be taken private by its creditors. Major M&A stories include prospective sales of […]

HBI Deals+Insights briefing May 2023: Deals+Insights members

Click here to see your Deals+Insights May 2023 In May's edition we look at the likelihood of a resurgence of M&A deals, consider whether PE should shift its focus from consolidation to boosting efficiency, and look at the prospects of increased outsourcing in the UK. Major deals covered include Mubadala-backed M42's reported $2bn+ purchase of […]

Despite oversupply, SHI in Germany outpaces PMI

It's not surprising in a country with an oversupply of healthcare that private medical insurance (PMI) expenditure is low. What may be surprising is despite this oversupply, statutory insurance expenditure is still growing at a faster rate than PMI.